Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin

Radiology

Volumn 254, Issue 1, 2010, Pages 261-269

  Goergen, Stacy K ^a   Rumbold, Gregory ^b   Compton, Gregory ^a   Harris, Claire ^b  

^a Southern Health ^*  (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GLUCOSE; IODINATED CONTRAST MEDIUM; LACTIC ACID; METFORMIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; DIABETIC PATIENT; DRUG MECHANISM; EVIDENCE BASED MEDICINE; GLUCONEOGENESIS; HUMAN; INTERVENTIONAL RADIOLOGY; KIDNEY FUNCTION; LACTIC ACIDOSIS; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK; SYSTEMATIC REVIEW; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; KIDNEY FUNCTION TEST; REVIEW;

ACIDOSIS, LACTIC; CONTRAST MEDIA; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FUNCTION TESTS; METFORMIN; PRACTICE GUIDELINES AS TOPIC; RISK;

EID: 75349095555     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.09090690     Document Type: Article

References (28)

1. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-579.
2. Lada P, Idrees U. Toxicity of oral agents used to treat diabetes. J Pharm Pract 2005;18(3):145-156.
3. Parra D, Legreid AM, Beckey NP, Reyes S. Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media. Pharmacotherapy 2004;24(8):987-993.
4. Hermann LS, Melander A. Biguanides: basic aspects and clinical uses. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, eds. Textbook of diabetes mellitus. New York, NY: Wiley, 1992; 773-795.
5. Quader MA, Sawmiller C, Sumpio BA. Contrast-induced nephropathy: review of incidence and pathophysiology. Ann Vasc Surg 1998;12(6):612-620.
6. Lalau JD, Lacroix C, Compagnon P, et al. Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care 1995;18(6):779-784.
7. Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews, 2006. No. CD002967. http://www.cochrane.org/reviews/. Published online January 25, 2006. Accessed March 2009.
8. Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database of Systematic Reviews, 2002. No. CD002967. http://www.cochrane.org/reviews/. Published online February 27, 2002. Accessed March 2009.
9. The AGREE Collaboration. Appraisal of Guidelines for Research & Evaluation. AGREE Instrument. http://www.agreecollaboration.org. Published September 2001. Accessed March 2009.
10. American College of Radiology. Manual on con trast media, version 6 http://www.acr.org/SecondaryMainMenuCategories/quality-safety/contrast-manual. aspx. Published 2008. Accessed March 2009.
11. Royal Australian and New Zealand College of Radiologists. Guidelines for metformin hydrochloride and intravascular contrast media. http://www.ranzcr.edu. au/collegegroups/reference/EBM/mhicm-guidelines.cfm. Published 2003. Accessed March 2009.
12. Royal College of Radiologists. Standards for iodinated intravascular contrast agent administration to adult patients. http://www.rcr.ac.uk/docs/ radiology/pdf/IVcontrast-PrintFinal.pdf. Published 2005. Accessed March 2009.
13. Canadian Association of Radiologists. Consensus guidelines for the prevention of contrast induced nephropathy. http://www.carj.ca/issues/2007-Apr/ 79/79.pdf. Published 2007. Accessed March 2009.
14. European Society of Urogenital Radiologists. ESUR guidelines on contrast media. http://www.esur.org/fileadmin/Guidelines/ESUR-2007-Guideline-6-Kern- Ubersicht.pdf. Published 2007. Accessed March 2009.
15. Thomsen HS, Morcos SK. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee. Eur Radiol 1999;9:738-740.
16. Jackson N. Metformin associated lactic acidosis following administration of intravenous contrast media. Centre for Clinical Effectiveness. Evidence Centre Evidence report, 2002. Health Technology Assessment (HTA) database. York, England: Centre for Reviews and Dissemination, University of York, 2002. www.crd.york.ac.uk. Published August 11, 2003. Accessed March 2009.
17. McCartney MM, Gilbert FJ, Murchison LE, Pearson D, McHardy K, Murray SD. Metformin and contrast media: a dangerous combination? Clin Radiol 1999;54:29-33.
18. Nawaz S, Cleveland T, Gaines PA, Chan P. Clinical risk associated with contrast angiography in metformin treated patients: a clinical review. Clin Radiol 1998;53:342-344.
19. Millican S, Cottrell N, Green B. Do risk factors for lactic acidosis influence dosing of metformin? J Clin Pharm Ther 2004;29:449-454.
20. Chan NN, Brain HPS, Feher MD. Metformin-associated lactic acidosis: a rare or very rare clinical entity? Diabet Med 1999;16:273-281.
21. Lalau JD, Race JM. Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin-associated lactic acidosis.' Diabetes Obes Metab 2001;3:195-201.
22. Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 2002;162(4):434-437.
23. Jain V, Sharma D, Prabhakar H, Dash HH. Metformin-associated lactic acidosis following contrast media-induced nephrotoxicity. Eur J Anaesthesiol 2008;25(2):166-167.
24. Stades AM, Heikens JT, Erkelens DW, Holleman F, Hoekstra JBL. Metformin and lactic acidosis: cause or coincidence? a review of case reports. J Intern Med 2004;255:179-187.
25. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000;36(5):1542-1548.
26. Bashore TM, Bates ER, Berger PB, et al. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37(8):2170-2214. http://www.acc.org/ qualityandscience/clinical/consensus/angiography/angiography-ref.htm. Published 2001. Accessed March 2009.
27. Heupler FA Jr. Guidelines for performing angiography in patients taking metformin. Members of the Laboratory Performance Standards Committee of the Society for Cardiac Angiography and Interventions [editorial]. Cathet Cardiovasc Diagn 1998;43:121-123.
28. Prinseau J, Jardin F, Sanchez A, et al. Acute renal failure after intravenous urography in diabetics: incidence of lactic acidosis in metformin treatment [in French]. Ann Med Interne (Paris) 1977;128(2):173-177.